Europe Prefilled Syringes Market worth $4.30 billion by 2030
The report "Europe Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic Syringe), Design (Single-chamber, Dual-chamber), Application (Diabetes, Cancer, Rheumatoid Arthritis, Other), & Country - Forecast to 2030", is projected to reach USD 4.30 billion by 2030 from USD 2.63 billion in 2025, at a CAGR of 10.4% during the forecast period.
Browse 150 market data Tables and 60 Figures spread through 200 Pages and in-depth TOC on "Europe Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic Syringe), Design (Single-chamber, Dual-chamber), Application (Diabetes, Cancer, Rheumatoid Arthritis, Other), & Country - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-prefilled-syringes-market-92797006.html
The growth of the Europe prefilled syringes market is primarily driven by the rising prevalence of chronic diseases requiring long-term therapies, the growing elderly population globally, and the increasing adoption of biological drugs, which often require precise dosing and administration. However, stringent regulations for approval processes and safety issues associated with pre-filled syringes can affect market growth, requiring continuous innovation and rigorous testing to overcome these barriers.
Conventional prefilled syringes segment is expected to account for the largest market share, by type, during the forecast period.
The conventional prefilled syringes segment holds the largest share in the Europeprefilled syringes market due to its widespread adoption across various therapeutic areas. These syringes are pre-filled with a specific dosage of medication, ensuring convenience and precise dosing for healthcare providers and patients. They are favored for their ease of use, reduced risk of contamination, and compatibility with a wide range of drugs. This segment’s dominance is driven by its versatility and by established manufacturing processes that support large-scale production to effectively meet global healthcare demands. Conventional prefilled syringes account for a significant share of the prefilled syringe segment because they are widely used across various therapeutic applications. These syringes are prefilled with a specific dosage of medication, ensuring ease of use and precise doses for health care providers and patients. They are user-friendly, have a reduced chance of contributing to contamination, and are compatible with a variety of drugs. The versatility of this segment complements established manufacturing methods for high-scale production, ensuring adequate supply to meet healthcare needs.
Glass prefilled syringes segment is expected to account for the largest market share, by material, during the forecast period.
The glass prefilled syringes segment holds the largest share in the Europeprefilled syringe market, primarily due to its superior material properties and suitability for sensitive drug formulations. In general, glass syringes have some inherent advantages because they are inert; therefore, the risk of drug interaction or leaching is minimal. They are therefore ideal for biologics, vaccines, and other complex formulations. In addition, glass syringes are clear, allowing the drug to be seen and ensuring accurate dosage administration. However, they are less durable than plastic syringes. Improvements in glass technology have made glass syringes safer and more robust, reinforcing their dominance in the market.
Single-chamber prefilled syringes segment is expected to account for the largest share, by design, in the Europe prefilled syringes market during the forecast period.
The single-chamber prefilled syringes segment holds the largest share in the Europe prefilled syringes market due to its simple design and economic efficiency in drug delivery. The syringe has a single compartment prefilled with a specific medication, making it simple to manufacture and use. To reduce the risk of drug errors and facilitate easier handling, these syringes are widely used across various therapeutic areas, from vaccines to insulin.
Cancer segment to account for the largest share of the Europe prefilled syringes market during the forecast period.
The cancer segment holds the largest share in the Europe prefilled syringe market, owing to the increasing prevalence and rising demand for precise and targeted drug delivery systems. Among the significant advantages of prefilled syringes in oncology treatments are accurate dosing, reduced risk of contamination, and superior patient compliance. They can be used to deliver chemotherapeutics, monoclonal antibodies, and supportive care drugs, enabling tailored therapy and better patient outcomes. This segment’s performance underscores the indispensable role of prefilled syringes in advanced cancer treatments and ongoing innovations to address specific oncological conditions.
In 2024, Germany accounted for the largest share of the Europe prefilled syringes market.
The Europeprefilled syringes market is segmented into Germany, France, the UK, Italy, and Spain. Germany holds the largest share of the Europe prefilled syringes market, driven by its highly developed healthcare infrastructure and strong uptake of advanced medical and drug-delivery technologies. The country benefits from robust regulatory oversight that supports the adoption of safe and efficient injectable delivery formats, including prefilled syringes. The rising prevalence of chronic diseases requiring long-term injectable therapies continues to fuel demand, while Germany’s strong base of pharmaceutical and biotechnology companies, along with substantial investments in research and drug development, further reinforce its leading position in the regional market.
Key Market Players:
The key players in the Europeprefilled syringes market are BD (US), Gerresheimer AG (Germany), SCHOTT (Germany), West Pharmaceutical Services, Inc. (US), AptarGroup Inc. (US), Nipro (Japan), Baxter (US), Owen Mumford Ltd. (UK), Weigao Meidcal international Co., Ltd. (China), Credence MedSystems, Inc. (US), Novartis AG (Switzerland), Stevanato Group (Italy), Polymed (India), MedXL, Inc. (Canada), and Sharps Technology, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe Prefilled Syringes Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
